Trial Profile
Conversion to once-daily tacrolimus (Advagraf) from twice-daily (Prograf) in Simultanous Pancreas-Kidney Transplant (SPK) and Pancreas After Kidney (PAK) recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2015 New trial record